Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2025)
Healthy Extracts (HYEX) reported Total Non-Current Liabilities of $2.1 million for Q4 2025, up 235.58% on a YoY basis from $627847.0 in Q4 2024, and up 120.42% quarter-over-quarter from $955856.0 in Q3 2025.
Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2025) Analysis & Trends
Healthy Extracts has reported Total Non-Current Liabilities for 11 years, with the latest figure at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 235.58% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 235.58% YoY), and the FY2025 full-year result was $2.1 million, up 235.58% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $2.1 million, up from $955856.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $2.1 million in Q4 2025, with the low at $466314.0 in Q4 2021.
- Historically, Total Non-Current Liabilities has averaged $1.1 million across 5 years, with a median of $1.2 million in 2021.
- The largest YoY upside for Total Non-Current Liabilities was 911.83% in 2021 against a maximum downside of 81.4% in 2021.
- Healthy Extracts' Total Non-Current Liabilities stood at $466314.0 in 2021, then jumped by 62.01% to $755452.0 in 2022, then soared by 102.03% to $1.5 million in 2023, then sank by 58.86% to $627847.0 in 2024, then jumped by 235.58% to $2.1 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $2.1 million (Q4 2025), $955856.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Healthy Extracts | - | - | 957,429.00 | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 955,856.00 |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 627,847.00 |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 755,452.00 |
| Sep 30, 2022 | 605,461.00 |
| Jun 30, 2022 | 661,843.00 |
| Mar 31, 2022 | 490,277.00 |
| Dec 31, 2021 | 466,314.00 |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 634,057.00 |